Pharmacokinetic and Lipidomic Assessment of the In Vivo Effects of Parishin A-Isorhynchophylline in Rat Migraine Models

Figure 5

Metabolic pathway analysis: (a) for 1 h group and (b) for 24 h group.

(a)

(b)